Page last updated: 2024-08-24

azelnidipine and Adrenocortical Carcinoma

azelnidipine has been researched along with Adrenocortical Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ikeda, K; Inada, Y; Isaka, T; Tajima, N; Takada, Y; Tojo, K	1

Other Studies

1 other study(ies) available for azelnidipine and Adrenocortical Carcinoma

Article	Year
Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R. European journal of pharmacology, 2009, Mar-01, Volume: 605, Issue:1-3 Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Angiotensin II; Azetidinecarboxylic Acid; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line, Tumor; Cytochrome P-450 CYP11B2; Dihydropyridines; Gene Expression Regulation; Humans; Nitrophenols; Organophosphorus Compounds; Potassium Chloride; Steroid 11-beta-Hydroxylase	2009

Article

Year

Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.

European journal of pharmacology, 2009, Mar-01, Volume: 605, Issue:1-3

Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Angiotensin II; Azetidinecarboxylic Acid; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line, Tumor; Cytochrome P-450 CYP11B2; Dihydropyridines; Gene Expression Regulation; Humans; Nitrophenols; Organophosphorus Compounds; Potassium Chloride; Steroid 11-beta-Hydroxylase

2009